REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hajnal-Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Hajnal-Pharma Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Hajnal-Pharma Kft. is based in Hungary. The head office is in Sopron. The enterprise operates in the Pharmacies and Drug Stores industry. It was established on February 13, 2012. Hajnal-Pharma Kft. currently employs 8 (2024) people. In 2023, the company reported a net sales revenue increase of 13.98%. Its total assets grew by 3.41% over the same period. In 2023, Hajnal-Pharma Kft.’s net profit margin decreased by 1.03%.

Headquarters
Malompatak utca 10.
Sopron; Gyor-Moson-Sopron; Postal Code: 9400

Contact Details: Purchase the Hajnal-Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Hajnal-Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Hajnal-Pharma Kft. report to view the information.
Registered Capital:
Purchase the Hajnal-Pharma Kft. report to view the information.
Incorporation Date:
February 13, 2012
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Hajnal-Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
13.98%▲
Total operating revenue
14.04%▲
Operating profit (EBIT)
-0.32%▼
EBITDA
-1.08%▼
Net Profit (Loss) for the Period
-2.45%▼
Total assets
3.41%▲
Total equity
3.79%▲
Operating Profit Margin (ROS)
-0.96%▼
Net Profit Margin
-1.03%▼
Return on Equity (ROE)
-2.81%▼
Quick Ratio
-0.26%▼
Cash Ratio
-0.25%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo